Healthequity, Inc. (HQY) stock forecast and price target
Price $103.46 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($103.46)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends January 31, 2027 | $4.72 | +18.1% | $1.4B |
| Next fiscal year ends January 31, 2028 | $5.52 | +16.8% | $1.5B |
| Quarter after ends January 31, 2027 | $1.10 | +16.1% | $364M |
Consensus of the analysts covering Healthequity, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Our model vs. Wall Street
Analysts see 16.6% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Healthequity’s intrinsic value about 50% below today’s market value, and it scores 2.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Healthequity stock price target?
The average 12-month target from 15 analysts is $120.67, 16.6% above the current price of $103.46 Targets range from $108.00 to $142.00.
Is Healthequity a buy according to analysts?
The consensus rating is “None” (5 strong buy, 10 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Healthequity expected to earn?
Analysts expect EPS of $4.72 for the fiscal year ending January 31, 2027 and $5.52 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.